Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
7.80
+0.07 (0.91%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Cartesian Therapeutics Earnings Call Transcripts
Fiscal Year 2026
-
The meeting confirmed a quorum, elected three directors for terms expiring in 2029, and saw overwhelming approval for executive compensation and auditor ratification, each with 99% support. No questions were raised by stockholders during the Q&A.